Delek Logistics Partners LP DKL 深 滬
已收盤 05-08 16:00:00 美东时间
51.05
+0.030
+0.06%
華盛通- 最 高51.76
- 今 開50.51
- 成交量 7.12万股
- 最 低 49.4801
- 昨 收 51.02
- 總市值 27.14亿
- 52周最高 54.76
- 市盈率 靜 15.49
- 換手率 0.13%
- 52周最低 35.61
- 委 比 33.33%
- 總股本 5316.82万
- 歷史最高 54.76
- 量 比 1.01
- 振 幅 4.47%
- 歷史最低 -20.65
- 每 手 1
- 風險率 5.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Delek Logistics plans USD 800 million senior notes offering due 2034
Delek Logistics plans USD 800 million senior notes offering due 2034 Delek Logistics launched proposed private offering of USD 800 million senior notes due 2034. Net proceeds earmarked for repurchase or redemption of outstanding 7.125% Senior Notes due 2028. Proceeds also set to redeem portion of ou
05-04 20:56
Delek Logistics launches cash tender offer for 7.125% senior notes due 2028
Delek Logistics launches cash tender offer for 7.125% senior notes due 2028 Delek Logistics Partners launched cash tender offer for any and all outstanding 7.125% Senior Notes due 2028. Tender consideration set at USD 1,001.35 per USD 1,000 principal amount, plus accrued interest for accepted notes.
05-04 20:47
Earnings Scheduled For April 29, 2026
Companies Reporting Before The Bell • Extreme Networks (NASDAQ:EXTR) is likely ...
04-29 19:11
Delek Logistics Partners Q1 EPS $0.60 Misses $0.93 Estimate, Sales $297.466M Beat $241.650M Estimate.
Delek Logistics Partners (NYSE:DKL) reported quarterly earnings of $0.60 per share which missed the analyst consensus estimate of $0.93 by 35.48 percent. This is a 17.81 percent decrease over earnings of $0.73 per share
04-29 18:38
美股大行评级 | 瑞银大幅上调西部数据、希捷科技目标价！汇丰银行上调英特尔评级至"买入"，目标价从50美元升至95美元
今日重点评级关注：HC Wainwright & Co.：维持Century Therapeutics"买入"评级，目标价从2美元升至5美元；Oppenheimer：维持Climb Bio"跑赢大市"评级，目标价从10美元升至18美元
04-22 12:41
Mizuho Maintains Neutral on Delek Logistics Partners, Raises Price Target to $52
Mizuho analyst Gabriel Moreen maintains Delek Logistics Partners (NYSE:DKL) with a Neutral and raises the price target from $45 to $52.
04-21 21:16
美股大行评级 | 潜在涨幅499.25%！Cabaletta Bio获Guggenheim升目标价至16美元，维持"买入"评级
今日重点评级关注：Guggenheim：维持Cabaletta Bio"买入"评级，目标价从15美元升至16美元；HC Wainwright & Co.：维持Palvella Therapeutics"买入"评级，目标价从255美元升至270美元
03-25 10:31
Truist Securities Initiates Coverage On Delek Logistics Partners with Hold Rating, Announces Price Target of $57
Truist Securities analyst Gabe Daoud initiates coverage on Delek Logistics Partners (NYSE:DKL) with a Hold rating and announces Price Target of $57.
03-24 22:42
美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元
03-09 11:47
Delek Logistics EVP Reuven Spiegel Disposes of Common Units
Delek Logistics EVP Reuven Spiegel Disposes of Common Units Reuven Spiegel, Executive Vice President of Delek Logistics Partners LP, reported a disposal of common units of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technolog
03-07 10:19
